A single failed trial cost AstraZeneca more than its worst day in years, and that says something critical about the company.
It seems that the line between bank and fintech company is increasingly blurring. When I first started out as a reporter, ...
From signing corporate deals in February to a Texas bankruptcy court, this is one of the fastest collapses in renewable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results